![Peter Francis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Francis
Direktor/Vorstandsmitglied bei BENITEC BIOPHARMA INC.
Vermögen: 2 272 $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Megan Boston | F | 52 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 8 Jahre |
Jerel Banks | M | 49 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 8 Jahre |
J. Buchi | M | 69 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 11 Jahre |
Edward Smith | M | 53 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 4 Jahre |
Justin Mouchacca | M | - | 8 Jahre | |
Alan Hoffman | M | 66 |
Optiscan Pty Ltd.
![]() Optiscan Pty Ltd. Medical SpecialtiesHealth Technology Optiscan Pty Ltd. develops microscopic imaging technologies for medical markets. The company was founded in 1994 and is headquartered in Melbourne, Australia. | 3 Jahre |
Ian Griffiths | M | 54 |
Optiscan Pty Ltd.
![]() Optiscan Pty Ltd. Medical SpecialtiesHealth Technology Optiscan Pty Ltd. develops microscopic imaging technologies for medical markets. The company was founded in 1994 and is headquartered in Melbourne, Australia. | 3 Jahre |
Oliver Kidd | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 6 Jahre |
Philip Currie | M | 70 |
Optiscan Pty Ltd.
![]() Optiscan Pty Ltd. Medical SpecialtiesHealth Technology Optiscan Pty Ltd. develops microscopic imaging technologies for medical markets. The company was founded in 1994 and is headquartered in Melbourne, Australia. | 6 Jahre |
Kerrie Boyd | F | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 7 Jahre |
Peter Roelvink | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 9 Jahre |
Bryan Dulhunty | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 8 Jahre |
Ian Mann | M | 56 |
Optiscan Pty Ltd.
![]() Optiscan Pty Ltd. Medical SpecialtiesHealth Technology Optiscan Pty Ltd. develops microscopic imaging technologies for medical markets. The company was founded in 1994 and is headquartered in Melbourne, Australia. | 13 Jahre |
Jenni Lightowlers | F | - |
FAL Lawyers
| - |
Maria Kavallaris | F | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Gregory West | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 7 Jahre |
Darren Lurie | M | - | 3 Jahre | |
Peter William French | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 6 Jahre |
Bruce Andrew | M | 70 | 19 Jahre | |
Robert John Day | M | - | 18 Jahre | |
Sara Cunningham | F | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 2 Jahre |
Mel Bridges | M | 73 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 7 Jahre |
Ron Howard | M | - | 1 Jahre | |
Michael Corry | M | - | - | |
Susan MacLeman | F | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 4 Jahre |
Michael Catelani | M | 57 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 1 Jahre |
Iain Ross | M | 71 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 6 Jahre |
Raymond Laurence Whitten | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 4 Jahre |
David Williamson | M | - | 1 Jahre | |
Graeme Mutton | M | - | 3 Jahre | |
John Chiplin | M | 66 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 7 Jahre |
John W. Rawling | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 5 Jahre |
Paul Guerra | M | - | 1 Jahre | |
Deborah Ho | F | - | 1 Jahre | |
Andrew Dale | M | - | - | |
Sakura Holloway | F | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | - |
Paul Steele | M | - | - | |
Chris Wilson | M | - | - | |
Alexander Cappello | M | 68 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 1 Jahre |
Archie Fraser | M | - | 2 Jahre | |
David Suhy | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 6 Jahre |
Trent David Telford | M | - | 1 Jahre | |
Michael Graham | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 3 Jahre |
Georgina H. Kilfoil | F | 55 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 4 Jahre |
Robert Lees | M | - | - | |
Carl Stubbings | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 3 Jahre |
Jason Smythe | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 1 Jahre |
Cliff Holloway | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 2 Jahre |
David William Halliday | M | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Australien | 49 | 100,00% |
Vereinigte Staaten | 5 | 10,20% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Peter Francis
- Persönliches Netzwerk